Jerini AG - Earning & Dividend Analysis Snapshot

This detailed Report provides an Earnings and Dividends history for Jerini AG. Tabular results include up to a ten-year history of "as reported" Earnings per Share and Dividends per Share plus a calculation of the amount of earnings paid out over the year in dividends (i.e. Payout Ratio). Earnings and Dividends are presented on both a Quarterly and Annual basis. An annual Percent Change factor is calculated for both Earnings and Dividends.

Jerini AG. The Group's principal activity is discovery and development of novel peptide based drugs. The Group focus on the capitalization of the potential of peptidomimetic and small molecule substrates transformed by Group's novel drug discovery method to therapeutic drugs. The Group operates through two business segments Jerini Pharma and Peptide Technologies. The Jerini Pharma segment is engaged in the discovery and development of targeted therapeutics for hereditary angioedema, liver cirrhosis, cancer and inflammatory diseases. The Peptide Technologies segment serves the life science industry and research community by producing custom and catalogue peptides using its integrated array-based technology platforms.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report